10 month result of fin,min, biotin and no results. 5/26/2026
The user has been using finasteride, minoxidil, and biotin for 10 months with no noticeable regrowth. Suggestions include trying dutasteride, microneedling, and other treatments, but results remain uncertain.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity 10 month update: Dutasteride, Finasteride, Minoxidil, Microneedling
A user shared a 10-month hair loss treatment update using oral dutasteride, topical minoxidil, topical finasteride, microneedling, biotin, and saw palmetto. Replies praised the progress and suggested additional treatments like tretinoin and RU58841.
community Apart from Finasteride, Minoxidil, and Microneedling what are you doing to reverse balding?
Various treatments for hair loss include minoxidil injections, finasteride, dutasteride, microneedling, Nizoral shampoo, and supplements like vitamin D and biotin. Additional methods mentioned are red light therapy, scalp massages, lifestyle changes, and hair transplants.
community 4 years of Miioxidil and Finasteride, added Microneedling am I regrowing or what I should do more?
The user has been using Minoxidil, Finasteride, and biotin for hair regrowth over four years, recently adding microneedling with a derma pen. They are considering increasing microneedling frequency, trying minoxidil pills, and possibly using Dutasteride for better results.
community 3,5 month progress - 1mg Fin , topical Minoxidil , 0.5mg Dut
The user shared their 3.5-month progress using 1mg finasteride, topical minoxidil, and 0.5mg dutasteride, along with biotin, vitamin D, saw palmetto, and multivitamins. They reported improvements in hair regrowth with some dryness from minoxidil and use micro-needling weekly.
community 5 months, min/fin, biotin/folic acid/zinc, mn, massages, niacin, cipaxil
The conversation discusses hair loss treatments, including minoxidil, finasteride, biotin, folic acid, zinc, micro-needling, niacin, and cipaxil, with the user preparing for a hair transplant. The user experiences side effects with topical finasteride and is hesitant to try oral dutasteride.
Related Research
6 / 6 resultsresearch Androgenetic Alopecia: Therapy Update
This comprehensive review analyzes androgenetic alopecia treatments, discussing the mechanisms, costs, efficacy, and safety of FDA-approved drugs like minoxidil and finasteride, as well as newer non-FDA-approved options that have shown effectiveness across various studies.
research Minimally Invasive Non-Surgical Therapies for Androgenetic Alopecia: A Narrative Review of Clinical Evidence for Regenerative and Locally Acting Antiandrogen Treatments
This study reviewed evidence for six minimally invasive treatments for androgenetic alopecia, finding consistent support for platelet-rich plasma and topical finasteride, while other options like microneedling and intradermal dutasteride showed promise but need further and standardized research.
research Male androgenetic alopecia
This review examines male androgenetic alopecia and reports no new clinical results, offering insights to aid dermatologists in making informed therapeutic decisions.
research Comparison of Microneedling with Platelet Rich Plasma vs Minoxidil (5%)+Finasteride (0.1%) Topical Therapy in Androgenetic Alopecia: A Randomised Clinical Study
This study compared the effectiveness and safety of microneedling with PRP versus minoxidil and finasteride topical therapy in adult males with androgenetic alopecia, finding similar hair density improvements in both groups, though microneedling with PRP had a quicker onset of action.
research Physiopathology and current treatments of androgenetic alopecia: Going beyond androgens and anti‐androgens
This review discusses the physiopathology of androgenetic alopecia and evaluates various traditional and emerging treatments, reporting no new clinical results but highlighting the need for enhanced treatment strategies.
research Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short version
This guideline review by the European Dermatology Forum evaluates current treatments for androgenetic alopecia but reports no new research findings, aiming to assist dermatologists in selecting safe and effective therapies.